IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.316
NA - Nord America 489
EU - Europa 261
SA - Sud America 25
AF - Africa 11
OC - Oceania 4
Totale 5.106
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.759
US - Stati Uniti d'America 465
CN - Cina 322
HK - Hong Kong 189
IT - Italia 82
GB - Regno Unito 49
DE - Germania 33
NL - Olanda 28
BR - Brasile 21
CZ - Repubblica Ceca 15
FI - Finlandia 15
CA - Canada 13
IN - India 13
PL - Polonia 11
FR - Francia 8
MX - Messico 8
ZA - Sudafrica 8
TR - Turchia 7
VN - Vietnam 7
UA - Ucraina 6
AT - Austria 4
ID - Indonesia 4
AU - Australia 3
BE - Belgio 3
JP - Giappone 3
BD - Bangladesh 2
CL - Cile 2
ES - Italia 2
KR - Corea 2
KZ - Kazakistan 2
PH - Filippine 2
SE - Svezia 2
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
KI - Kiribati 1
LB - Libano 1
PY - Paraguay 1
SA - Arabia Saudita 1
VG - Isole Vergini Britanniche 1
YE - Yemen 1
Totale 5.106
Salva come PNG Salva come JPEG
Città #
Hong Kong 185
Singapore 169
Hefei 159
Ashburn 106
Shanghai 66
Beijing 62
Boardman 61
Rome 47
London 35
Los Angeles 22
Dallas 20
Munich 17
Amsterdam 16
San Francisco 16
Brno 15
New York 12
Santa Clara 12
Seattle 12
Turku 11
Boston 10
Warsaw 10
Council Bluffs 8
Pune 8
Toronto 8
Atlanta 6
Brooklyn 6
Mexico City 6
São Paulo 6
Guangzhou 5
Johannesburg 5
Helsinki 4
Washington 4
Brownsville 3
Canberra 3
Charlotte 3
Chennai 3
Chicago 3
Helena 3
Ho Chi Minh City 3
Manchester 3
Montreal 3
Tokyo 3
Vienna 3
Arayat 2
Bari 2
Buffalo 2
Camden 2
Central 2
Kharkiv 2
Liverpool 2
Messina 2
Paris 2
Perugia 2
Providence 2
Shenzhen 2
Stockholm 2
Wembley 2
Accra 1
Almere Stad 1
Ankara 1
Atibaia 1
Augusta 1
Benito Juarez 1
Brasília 1
Braço do Norte 1
Brussels 1
Budapest 1
Caldas Novas 1
Changchun 1
Changsha 1
Charleston 1
Ciudad del Este 1
Cleveland 1
Cold Lake 1
Conakry 1
Cuiabá 1
Dongguan 1
Foggia 1
Foligno 1
Frankfurt am Main 1
Genoa 1
Handan 1
Houston 1
Hyderabad 1
Itaquaquecetuba 1
Jackson 1
Jinan 1
Koekelberg 1
Las Vegas 1
Manaus 1
Markham 1
Milwaukee 1
Minsk 1
Montpellier 1
Nanyang 1
Ninh Bình 1
Oklahoma City 1
Pasadena 1
Penápolis 1
Philadelphia 1
Totale 1.233
Salva come PNG Salva come JPEG
Nome #
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 198
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 197
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 195
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 191
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 188
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 184
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 184
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 177
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 176
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 176
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 175
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 174
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 172
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 168
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 161
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 160
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 96
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 86
A challenging alfa-fetoprotein in a cirrhotic patient 85
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 84
ALT levels are associated with metabolic parameters and age in a large real-life population. 84
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 82
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 81
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 80
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 79
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 78
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 72
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 68
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 66
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 62
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 59
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 56
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 50
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 48
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 47
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 37
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 34
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 31
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 31
Pain and Frailty in Hospitalized Older Adults 31
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 29
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 29
Sarcopenia in Chronic Liver Disease: The Emerging Role of Ultrasound in Determining Muscle Mass, Strength and Clinical Outcomes 28
Renal impairment and anemia during triple therapy 27
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 25
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 25
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 24
What changed in the Italian internal medicine and geriatric wards during the lockdown 24
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 23
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 22
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 22
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 22
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 21
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 21
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 21
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 21
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 20
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 19
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 19
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 19
Steroid-refractory immune related hepatitis may hide viral re-activation 19
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 18
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 18
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 17
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 16
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 16
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 16
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 16
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 15
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 15
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 15
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 14
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 14
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 14
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 14
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 13
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 12
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 12
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 11
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 8
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 6
Totale 5.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 2 0 1 0 2 2 12 0 2 69
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024176 6 14 4 23 13 78 2 6 3 6 5 16
2024/20254.457 38 16 66 12 129 98 77 14 176 263 1.749 1.819
2025/2026421 243 156 22 0 0 0 0 0 0 0 0 0
Totale 5.163